We are a drug company specializing on stroke recovery medicines, and the only accredited distributor of FDA-approved NeuroAID II MLC 901 in the Philippines.
As a company in the healthcare industry, we commit to building stronger and healthier communities by improving human services and support systems, especially for those who need them most.
We are looking for self-driven people with a great ambition to be a part of a new market innovation that will introduce the Traditional Chinese Medicine concept that is evidence-based medicine compliant.
E* Chi’mes conducted a snack symposium with healthcare professionals, creating an engaging platform to present product insights in a more relaxed and interactive setting. The session encouraged open discussion on clinical applications and practical benefits, allowing participants to share experiences and perspectives while enjoying a brief break from their clinical duties. This activity reflects E* Chi’mes’ continued commitment to strengthening collaboration and providing acc
E* Chi’mes took part in UPFANS 2026 Day 1, themed “NeuroRevive 3.0: Igniting the Basics, Forging the Future.” The event gathered neurology professionals and healthcare partners for a day of learning, discussion, and innovation in neurological care. The program highlighted foundational concepts and emerging advancements in neurology, fostering deeper understanding and collaboration among attendees committed to improving patient outcomes. E* Chi’mes is proud to support initiati
E* Chi’mes participated in the PAVIN 2026 Convention Day, joining healthcare professionals and industry partners in a meaningful gathering focused on advancing clinical practice and professional collaboration. The event served as a platform for knowledge sharing, networking, and strengthening partnerships within the medical community, reinforcing E* Chi’mes’ commitment to supporting continuous learning and healthcare innovation.
